Overview
- Peptide (C)EQMQKVRGFR(S)GKKS, corresponding to amino acid residues 522 - 536 of mouse OCTN1 (Accession Q9Z306). Intracellular, C-terminus.
- Western blot analysis of mouse kidney lysates (lanes 1 and 3) and rat small intestine lysates (lanes 2 and 4):1-2. Anti-OCTN1/SLC22A4 Antibody (#ACT-014), (1:200).
3-4. Anti-OCTN1/SLC22A4 Antibody, preincubated with
OCTN1/SLC22A4 Antibody Blocking Peptide (BLP-CT014). - Western blot analysis of mouse brain membranes (lanes 1 and 3) and rat brain membranes (lanes 2 and 4):1-2. Anti-OCTN1/SLC22A4 Antibody (#ACT-014), (1:600).
3-4. Anti-OCTN1/SLC22A4 Antibody, preincubated with
OCTN1/SLC22A4 Antibody Blocking Peptide (BLP-CT014). - Western blot analysis of human THP-1 monocytic leukemia cell line lysates (lanes 1 and 4), mouse BV-2 microglia cell line lysates (lanes 2 and 5) and human HeLa cervix adenocarcinoma cell line lysates (lanes 3 and 6):1-3. Anti-OCTN1/SLC22A4 Antibody (#ACT-014), (1:400).
4-6. Anti-OCTN1/SLC22A4 Antibody, preincubated with
OCTN1/SLC22A4 Antibody Blocking Peptide (BLP-CT014).
Organic Cation Transporter Novel (OCTN) is a subfamily of the larger Organic Cation Transporter (OCT) or SLC22 transporter family.
The OCTN subfamily consists of two members in humans: OCTN1 (SLC22A4) and OCTN2 (SLC22A5) with a third member (SLC22A21) present only in rodents 1-2.
The physiological role of OCTN1 (SLC22A4) has not yet been elucidated. OCTN1 is ubiquitously expressed throughout the body and transports various therapeutic agents, including organic cations and zwitterions. Ergothioneine (ET/ ERGO) a natural diet-derived antioxidant was found to be a specific substrate of OCTN1 3.
OCTN1 is functionally expressed in neurons and neural stem cells and activation of the transporter could conceivably have a protective role in neurodegenerative diseases. In addition, in peripheral organs, mutations in OCTN1 are associated with susceptibility to Crohn’s disease and rheumatoid arthritis suggesting that OCTN1 may play a role in inflammatory dieseases 1.